Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

RESISTANCE TO POTENT AND BROADLY ACTIVE HIV-1 MATURATION INHIBITORS

By Enthusiast Inc MDFebruary 15, 2017

…late step in protease-mediated Gag processing: the cleavage of the capsid-spacer peptide 1 (CA-SP1) intermediate into mature CA. BVM was shown to be safe and effective in reducing viral loads…

861 – Cardiometabolic Effects of Semaglutide in People With HIV: The SLIM LIVER Study

By Jimmy He PharmD, DScMarch 20, 2025

…a steatohepatitis surrogate) occurred in women (women: 68% to 42%, p=0.06; men: 43% to 41%). Significant changes in adiponectin (↑), leptin (↓) and CRP (↓) were observed, with no change…

Refinement of Association Signals Assessment of Residual Heritability in Host Control of HIV Viral Load

By Enthusiast Inc MDFebruary 27, 2015

…centers. Plasma viral load measurements obtained during the chronic phase of untreated infection were available for 6,315 individuals of European ancestry. Missing genotypes were imputed using the 1,000 Genomes Project…

EVALUATING THE LINK BETWEEN MITOCHONDRIAL STATE & HIV-SPECIFIC CD8+ T CELL EXHAUSTION

By Enthusiast Inc MDMarch 6, 2018

…Distinct metabolic features, such as increased mitochondrial mass (MM), decreased mitochondrial membrane potential (MMP), and increased reactive oxygen species (ROS) content are related to greater antigen-specific exhaustion. Yet, the contribution…

Decreased Frequency of Colon-Resident Memory T-Cells Is Associated With HIV-1 Persistence on ART

By Jimmy He PharmD, DScMarch 6, 2024

…was assessed in 15 PLWH after stimulation with HIV-1 peptide pools and measurement of IFNγ production, degranulation (CD107a), and cell proliferation (CFSE). Results: CD4+ and CD8+ TRM cells were significantly…

1344 – Injectable Cabotegravir PrEP Discontinuations at a Peer Specialist-Led Program in Washington, DC

By Jimmy He PharmD, DScMarch 20, 2025

…with 677 injections (median 3; range 1-12). Users were 52% White, 32% Black, 18% Latino, median age was 34 years (range 21- 62), 2% women, 80% men who have sex…

Hormonal Contraceptives Increase Innate Immune Effector Molecules in Cervicovaginal Secretions

By Enthusiast Inc MDSeptember 29, 2014

…Combining HESN and low-risk control women, compared to women not using hormonal contraception, DMPA users had significantly higher mean levels of HNP1-3 (2.38 vs. 2.05 log10 ng/ml; p=0.024) and LL-37…

PROVIRAL LANDSCAPE IN HIV-1 POST-TREATMENT CONTROLLERS AND NON-CONTROLLERS

By Enthusiast Inc MDMarch 5, 2018

…cytometry, and T cell intracellular cytokine staining was performed on PBMCs stimulated with an HIV [i]gag[/i] peptide pool. We obtained a total of 1193 proviral genomes. PTCs had approximately 6-fold…

A FIELD-BASED SAMPLING STRATEGY TO REVISE HIV TREATMENT PROGRAM RETENTION ESTIMATES

By Jimmy He PharmD, DScApril 27, 2020

Loss to follow-up (LTFU) in Zambia’s national treatment program threatens progress toward achieving HIV epidemic control. With CDC/PEPFAR funding, the Centre for Infectious Disease Research in Zambia (CIDRZ) supports the…

ANALYSIS OF RECENT INFECTION AMONG PERSONS NEWLY DIAGNOSED WITH HIV IN NIGERIA

By Jimmy He PharmD, DScApril 4, 2022

…transmission to achieve epidemic control. The PEPFAR team in Nigeria introduced recency testing in 2020. We analyzed recent infection among newly diagnosed PLHIV in 10 states. Testing for recent infection…

←1
23456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354
…5556575859…
6061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top